PERK-IN-6

CAS No. 1337532-14-5

PERK-IN-6( —— )

Catalog No. M36418 CAS No. 1337532-14-5

PERK-IN-6 is a novel and highly potent PERK inhibitor (IC50:2.5 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 246 Get Quote
5MG 375 Get Quote
10MG 559 Get Quote
25MG 864 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PERK-IN-6
  • Note
    Research use only, not for human use.
  • Brief Description
    PERK-IN-6 is a novel and highly potent PERK inhibitor (IC50:2.5 nM).
  • Description
    PERK-IN-6 (Compound 5) is a PERK inhibitor with an IC50 of 2.5 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    PERK
  • Recptor
    PERK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1337532-14-5
  • Formula Weight
    398.46
  • Molecular Formula
    C23H22N6O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NC1=C2C(=CN(C)C2=NC=N1)C=3C=C4C(=CC3)N(C(CC=5N=C(C)C=CC5)=O)CC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Axten JM, et al. Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development. ACS Med Chem Lett. 2013 Aug 12;4(10):964-8.?
molnova catalog
related products
  • Salubrinal

    Salubrinal is a selective inhibitor of eukaryotic translation initiation factor 2 subunit α (eIF2α) dephosphorylation.

  • δ-Tocotrienol

    δ-Tocotrienol is a potential angiogenic inhibitor. δ-Tocotrienol is also a nontoxic activator of mir-34a which can inhibit nonsmall cell lung cancer cells (NSCLC) cell proliferation, induce apoptosis and inhibit invasion, and thus offering a potential starting point for the design of novel anticancer agents.

  • rac-BHFF

    Rac-BHFF is potent and selective GABA B receptor positive allosteric modulator that increases the potency and efficacy of GABA ( > 15-fold and > 149% respectively).